InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the detailed record of transactions filed by Reinhard Amy, Director. Insider active across 2 companies, notably Gannett Co., Inc.. Aggregated, 8 disclosures have been logged. History available since 7 June 2022. The latest transaction was disclosed on 31 December 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations
Amy E. McKee is a Director at BIOCRYST PHARMACEUTICALS INC. She contributes to corporate governance and the strategic direction of the company. As a board member, she participates in important decision-making and oversight of BIOCRYST's operations. Her experience in the biopharmaceutical sector is an asset for the company.